AzTrials
AzTrials

Sodium ExcessNCT05735457

A Short, Animated Storytelling Video to Increase Knowledge About Sodium Intake as a Cardiovascular Risk Factor

A study testing A short, animated storytelling video on dietary sodium in people with Sodium Excess and Cardiovascular Risk Factor, run by University Hospital Freiburg.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will evaluate the effect of a short, animated storytelling intervention video on sodium intake as a major risk factor for cardiovascular disease on immediate and medium-term retention of knowledge about the risks of cardiovascular diesaes due to increased sodium intake. Read more about this study

Who is it for?
Ages 18 to 59 yearsHealthy volunteers can take part
What is being tested?
A short, animated storytelling video on dietary sodium
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
10,000 participants
Where
No sites listed yet
Study dates
1 Jun 2023to 31 Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Registration with the Prolific Academic platform

Who cannot join

  • none

Trial locations and contacts

No sites are listed yet.

About this study

Official title: A Short, Animated Storytelling Video to Increase Knowledge About Sodium Intake as a Major Cardiovascular Risk Factor and to Give Recommendations for a Low-sodium Healthy Diet: an Online, Randomized, Controlled Trial

This study will evaluate the effect of a short, animated storytelling intervention video on sodium intake as a major risk factor for cardiovascular disease on immediate and medium-term retention of knowledge about the risks of cardiovascular diesaes due to increased sodium intake. We will also measure voluntary engagement with the content of the short, animated storytelling intervention video on positive psychological capital.

In this 4-armed, parallel, randomized controlled trial, 10,000 adult, US participants will be randomly assigned to (1) a short, animated storytelling intervention video on sodium as a cardiovascular disease risk factor followed by surveys assessing the facts om sodium and cardiovascular disease conveyed in the video (2) the surveys only, (3) an attention placebo control video followed by the before mentioned surveys, and (4) an arm that is exposed to neither the video nor the surveys. Two weeks later, participants in all four arms will complete all of the surveys.

The primary outcome is knowledge about the cardiovascular disease risk associated with increased sodium intake (immediate and medium-term). The major scondary outcome is the extent of voluntary engagement with the short, animated storytelling video content.

Being tested
A short, animated storytelling video on dietary sodium, A short, animated storytelling attention placebo video
Medical subject headings
Hypernatremia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A short, animated storytelling video on dietary sodiumOther

    Participants in the Intervention Arm will view a short, animated storytelling video on dietary sodium and the risks of cardiovascular disease due to increased intake of sodium.

  • A short, animated storytelling attention placebo videoOther

    The Attention Placebo Control Arm will view an attention placebo control video, unrelated to the outcomes measured in this trial.

Study groups in NCT05735457
Study groupRoleWhat they receive
Intervention ArmExperimentalParticipants will be shown a short, animated storytelling (SAS) video on dietary sodium and thereafter be asked to complete a questionnaire to assess knowledge on dietary sodium and behavioral expectation. Two weeks later, participants will once again be asked to complete the knowledge and behavioral expectation questionnaire.
Receives: Other: A short, animated storytelling video on dietary sodium
Exposed Control ArmNo interventionParticipants will be asked to complete a questionnaire to assess knowledge on dietary sodium and behavioral expectation (the same questionnaire as in arm 1, however, without being exposed to the SAS video on dietary sodium before. Two weeks later, participants will once again be asked to complete the knowledge and behavioral expectation questionnaire.
Attention Placebo Control ArmPlacebo comparatorParticipants will be shown a attention placebo control (APC) video, unrelated to the outcomes measured in this trial, before being asked to complete the knowledge and behavioral expectation questionnaire. Two weeks later, participants will once again be asked to complete the knowledge and behavioral expectation questionnaire.
Receives: Other: A short, animated storytelling attention placebo video
Un-exposed Control ArmNo interventionParticipants will not view a video and will not be asked to complete the questionnaire. Two weeks later, participants will once again be asked to complete the knowledge and behavioral expectation questionnaire.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Immediate effect of the short, animated storytelling intervention video on knowledge about dietary sodium as a cardiovascular risk factor

    The immediate effect of the short, animated storytelling intervention video on knowledge about dietary sodium as a cardiovascular risk factor assessed by a sodium questionnaire containing 30 questions.

    Measured: immediately after watching the video

  2. Medium-term effect of the short, animated storytelling intervention video on knowledge about dietary sodium as a cardiovascular risk factor

    The medium-term effect of the short, animated storytelling intervention video on knowledge about dietary sodium as a cardiovascular risk factor assessed by a sodium questionnaire containing 30 questions.

    Measured: 2 weeks after watching the video

Secondary outcomes (4)
  1. Immediate effect of the short, animated storytelling intervention video on behavioral expectation to reduce dietary sodium.

    The immediate effect of the short, animated storytelling intervention video on behavioral expectation to reduce dietary sodium assessed by a questionnaire containing 30 questions on behavioral expectation.

    Measured: immediately after watching the video

  2. Medium-term effect of the short, animated storytelling intervention video on behavioral expectation to reduce dietary sodium.

    The medium-term effect of the short, animated storytelling intervention video on behavioral expectation to reduce dietary sodium assessed by a questionnaire containing 30 questions on behavioral expectation.

    Measured: 2 weeks after watching the video

  3. Voluntary post-trial engagement (frequency) with the video content.

    Assessment of the frequency (absolute number) of watching the trial videos after completion of the trial questionnaires

    Measured: 2 weeks after entering the trial

  4. Voluntary post-trial engagement (duration) with the video content.

    Assessment of the duration (in minutes) of watching the trial videos after completion of the trial questionnaires

    Measured: 2 weeks after entering the trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start1 Jun 2023 (estimated)
  3. Primary completion31 Jul 2023 (estimated)
  4. Study completion31 Aug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05735457
Sponsor's protocol ID
EduEntertainSodium_23
Status last verified
May 2023
First submitted
31 Jan 2023
Last updated
10 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Adam M, Rohr JK, Greuel M, Nguyen VK, Abd El Aziz M, Uberreiter C, Coles O, Barnighausen T, Supady A. Digital storytelling boosts knowledge and behavioral expectation to reduce dietary sodium: a randomized controlled trial. NPJ Digit Med. 2026 Jan 9;9(1):21. doi: 10.1038/s41746-025-02258-x.

    PubMed 41514069
  • Supady A, Nguyen K, Aziz MAE, Uberreiter C, Barnighausen T, Adam M. A short, animated storytelling video about sodium intake as a major cardiovascular risk factor and recommendations for a healthy diet: an online, randomized, controlled trial. Trials. 2023 Jun 10;24(1):390. doi: 10.1186/s13063-023-07418-6.

    PubMed 37296468

Questions about this trial

What is this clinical trial studying?

A study testing A short, animated storytelling video on dietary sodium in people with Sodium Excess and Cardiovascular Risk Factor, run by University Hospital Freiburg.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alexander Supady, MD, MPH (+4976127073790, alexander.supady@uniklinik-freiburg.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Immediate effect of the short, animated storytelling intervention video on knowledge about dietary sodium as a cardiovascular risk factor (time frame: immediately after watching the video). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05735457, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in